ArticleBeyoglu eye journal2026
Impact of Prior Ahmed Glaucoma Valve Implantation on Surgical Success and Prognosis in Eyes Undergoing Keratoplasty.
Article in Beyoglu eye journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the surgical outcomes and prognosis of patients who underwent Descemet membrane endothelial keratoplasty (DMEK) or penetrating keratoplasty (PK) following Ahmed glaucoma valve (AGV) implantation. Methods: Patients who underwent keratoplasty at the cornea department of our hospital between April 2016 and April 2024 were retrospectively reviewed. Patients with a history of prior AGV implantation were included. Surgical success was defined as maintaining graft clarity for a minimum of 6 months post-keratoplasty. Results: A total of 13 eyes of 13 patients (four women, nine men) with a mean age of 62.0±16.0 years were included. Five patients had a history of multiple glaucoma surgeries prior to AGV implantation. Among the included patients, six had no history of corneal transplantation before AGV implantation, whereas four had previously undergone PK, and two had undergone DMEK. One patient had received two DMEK procedures followed by PK. No tube-related complications, including endothelial touch, were observed. Corneal decompensation developed at a mean of 12.7±10.5 months after AGV implantation, prompting PK in four patients, repeat PK in five patients, and DMEK in four patients. The mean follow-up period after keratoplasty was 21.3±17.3 months. Although the best-corrected visual acuity (BCVA) achieved postoperatively was 1.5 (0.4-2.3) LogMAR at a mean of 13.9±12.3 months, there was no statistically significant difference between pre-operative BCVA (2.3 [1.0-2.3] LogMAR) and final post-operative BCVA (2.3 [0.4-2.7] LogMAR) (p=0.735). Similarly, no significant change was observed in intraocular pressure before and after keratoplasty (p=0.283). A second keratoplasty was recommended in five cases after the initial keratoplasty. At the final follow-up, graft rejection was observed in eight patients, two of whom developed keratitis. The overall surgical success rate was calculated as 23.1%. Conclusion: In patients undergoing keratoplasty for corneal decompensation following AGV implantation, both graft survival and overall surgical outcomes were found to be unfavorable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.